Sino Biopharmaceutical | 1177 - Operating Expenses


Sino Biopharmaceutical reported CNY12.39B in Operating Expenses for its fiscal semester ending in June of 2025.





Operating Expenses Change Date
Akebia Therapeutics USD 63.08M 8.26M Dec/2025
Alaunos Therapeutics USD 1.01M 175K Mar/2026
Avita Medical AUD 28.56M 534K Jun/2026
Cspc Pharmaceutical CNY 5.91B 512.77M Dec/2025
Dianthus Therapeutics USD 62.24M 15.25M Jun/2026
Ionis Pharmaceuticals USD 370.24M 6.24M Jun/2026
IQVIA Holdings USD 3.82B 2.05B Sep/2026
Jiangsu Hengrui CNY 6.01B 449.22M Sep/2026
Moderna USD 960M 817M Jun/2026
Organon & Co USD 1.19B 187M Sep/2026
Revvity USD 603.55M 24.8M Jun/2026
Sino Biopharmaceutical CNY 12.39B 1.26B Jun/2025
Tectonic Therapeutic USD 24.22M 3.08M Jun/2026
Viatris USD 3.68B 145.9M Jun/2026
Xeris Pharmaceuticals USD 86.93M 11.72M Jun/2026